Viewing Study NCT04429724


Ignite Creation Date: 2025-12-18 @ 8:14 AM
Ignite Modification Date: 2025-12-23 @ 9:48 PM
Study NCT ID: NCT04429724
Status: None
Last Update Posted: 2022-05-10 00:00:00
First Post: 2020-06-10 00:00:00
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Health Professional Exposure Assessment to Covid-19
Sponsor: None
Organization:

Study Overview

Official Title: Health Professional Exposure Assessment to Covid-19
Status: None
Status Verified Date: 2022-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: SERODRON
Brief Summary: This is a multi-center, prospective, interventional, low-risk, low-constraint, biological collection study to assess the exposure of health care workers to COVID-19.

Three blood samples will be taken at day 1, month 3 and month 6. The blood samples will be stored in a serum biological collection. A prospective data collection will be set up at the level of symptoms and co-morbidities at each collection at D1, M3 and M6.

In the event of the appearance of symptoms between samples, a self-questionnaire will be completed by the participating personnel as well as an invitation to screening by RT-PCR SARS Cov2 according to standard practices in force at the national level as well as an additional serological test.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: